Curaleaf Holdings Inc

New Approach Montana resumed its marijuana legalization campaign in May. The group submitted plenty of signatures and qualified for the November ballot.

OrganiGram (NASDAQ:OGI) stock is trading higher before its third-quarter earnings. The stock closed with a gain of 3.9% at $1.58 on Wednesday.

Curaleaf (OTCMKTS:CURLF) is one of the vertically integrated US cannabis companies. The company has been a top player in the US cannabis space.

Marijuana legalization in Idaho had to bear the brunt of the coronavirus pandemic. The lockdown forced the state to suspend its medical marijuana campaign.

KushCo Holdings’ third-quarter net revenue was $22.3 million, which was much lower than analysts’ estimate of $31.1 million.

Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.

KushCo Holdings will likely report its third-quarter results on Wednesday. The company will have an earnings call before the market opens.

To survive amid the current COVID-19 crisis, OrganiGram (NASDAQ:OGI) announced restructuring changes including a 25% cut in its workforce.

Curaleaf (OTCMKTS:CURLF) acquired a “Select” brand in February 2020. The company received positive feedback in medical and adult-use markets.

On June 27, Green Thumb Industries (OTCMKTS:GTBIF) opened its fifth Essence brand store in Las Vegas and its 48th retail store in the US.

Acreage Holdings’ first-quarter pro forma revenue grew 65% YoY (year-over-year) to $37.6 million. The revenue beat analysts’ estimates of $34.9 million.

Canopy Growth entered into an agreement with US-based cannabis company Acreage Holdings last year. However, the company announced some changes.

Acreage Holdings (OTCMKTS:ACRGF) will likely report its results for the first quarter of fiscal 2020 on Friday before the market opens.

The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.

While most businesses suffered amid COVID-19, marijuana saw a drastic rise in sales. Many states have been rethinking the benefits of marijuana legalization.

On June 11, Charlotte’s Web announced that it completed the acquisition of Abacus Health. The company’s performance wasn’t strong in the first quarter.

On Monday, Curaleaf Holdings announced that it will expand its Select brand products in Connecticut. The products will be available at medical dispensaries.

Innovative Industrial Properties has continued its aggressive expansion. IIPR acquired a new property in Pennsylvania from Holistic Industries.

On Monday, Green Thumb Industries (OTCMKTS:GTBIF) opened a Rise brand store in Chambersburg, Pennsylvania—its 46th store in the US.

US states have been looking at strategies to gather signatures and qualify for the 2020 ballot. The pandemic made gathering signatures a challenge.

In the 2020 New Mexico Democratic presidential primaries election on June 2, voters ousted most of the Senate candidates who opposed marijuana legalization.

Bermuda wants to expand its legal cannabis market. The government wants public feedback before the upcoming Bermuda Parliament sessions.

Cresco Labs (OTCMKTS:CRLBF) is trading 1.8% higher as of 9:44 AM ET today. The company received a provisional processing license by the state of Ohio.

George Floyd’s death has led to mass protests in the US. Notably, social injustice was one of the main motives behind legalizing marijuana.

Cresco Labs (OTCMKTS:CRLBF) is one of the US cannabis companies that has been consistently performing well despite the marijuana industry’s struggles.

Amid the protests following George Floyd’s death in the US, MedMen temporarily closed all of its stores. The stock fell after the news.

So far in 2020, Green Thumb Industries has returned 6.0%—one of the few cannabis companies with positive returns this year.

Cresco Labs (OTCMKTS:CRLBF) will likely report its financial results for the first quarter of fiscal 2020 on May 28 after the market closes.

MedMen Enterprises (OTCMKTS:MMNFF) is scheduled to report its financial results for the third quarter of fiscal 2020 on May 27 after the market closes.

Earlier this week, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings. The company missed analysts’ revenue expectations.

Marijuana is an old but growing market in California. Notably, California became the first state to legalize medical marijuana in 1996.

The cannabis industry is doing its own research amid COVID-19. Researchers discovered that marijuana might have properties to fight the coronavirus.

Democrats and Republicans have always had opposing views about marijuana legalization. Republicans could gain voters if they support legalization.

Canopy Growth (NYSE:CGC)(TSE:WEED) still has investors’ attention despite all that the marijuana industry has gone through.

On Monday, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings after the market closed. The company reported revenue of $96.5 million.

Green Thumb Industries reported impressive results for the first quarter of fiscal 2020 on Thursday after the market closed.

Texas has suffered huge economic losses. Many industry experts think that marijuana legalization could be a good option to revive the state’s economy.

Analysts expect Curaleaf’s EBITDA to rise during the quarter. They expect the company to report an EBITDA of $15.7 million.

Today, Charlotte’s Web reported a mixed first-quarter performance. For the quarter ended on March 31, the company reported revenues of $21.7 million.

Charlotte’s Web Holdings (OTCMKTS:CWBHF)(NYSEARCA:CWEB) will likely report its first-quarter earnings before the market opens on May 14.

On May 6, Innovative Industrial Properties reported its first-quarter results after the market closed. The company posted an adjusted EPS of $0.72.

IIPR will likely report its first-quarter earnings, which ended on March 31, after the market closes on May 6. So, should you buy the stock?

Amid COVID-19, people rushed to stock up on marijuana. Lebanon is the first Middle East country to legalize medical marijuana amid the pandemic.

Cresco Labs reported its results for the fourth quarter of fiscal 2019 on April 27. Analysts were hopeful about the company’s fourth-quarter earnings.

Analysts expect Cresco Labs to report revenue of $43.7 million in the fourth quarter—YoY growth of 157.9% from $17.0 million in the fourth quarter of 2018.

Cronos Group will report its fourth-quarter and fiscal 2019 results after the market closes today—a delay from the original date of February 27.

Charlotte’s Web Holdings reported its fourth-quarter earnings on March 24. For the quarter, the company missed analysts’ revenue and EBITDA estimates.

Since Curaleaf reported its fourth-quarter earnings on March 24, Alliance Global Partners and Canaccord Genuity have lowered their target prices.

Marijuana activists in Arizona started the “Smart & Safe Arizona Initiative” as a ballot measure for 2020. The group gathered enough signatures.

As the markets start to rebound, three cannabis stocks could deliver strong returns. Cannabis sales have increased amid the coronavirus outbreak.

Amid the coronavirus pandemic, marijuana has become an essential item in many US states. As a result, there was a surge in cannabis demand.

On Tuesday, Curaleaf (OTCMKTS:CURLF) reported its fourth-quarter earnings after the market closed. The company reported revenue of $75.46 million.

Today, Charlotte’s Web Holdings (TSE:CWEB)(OTCMKTS:CWBHF) reported its fourth-quarter earnings. For the quarter, the company reported revenues of $22.8 million.

Curaleaf Holdings (OTCMKTS:CURLF) will report its fourth-quarter earnings after the market closes on March 24. Analysts are bullish on Curaleaf.

The FDA doesn’t allow CBD products to be used as a food derivative. The agency has been hesitant about how some cannabis companies market CBD products.

Charlotte’s Web Holdings (NYSEARCA:CWEB) will report its earnings for the fourth quarter of 2019 before the market opens on March 24.

On March 16, Roth Capital initiated coverage on Innovative Industrial Properties (NYSE:IIPR) with a “buy” rating and a stock price of $110.

Wall Street favors a “hold” rating for Supreme Cannabis. Four analysts recommend a ‘hold,’ three recommend a ‘buy,’ and one recommends a ‘sell.’

On Wednesday, Charlotte’s Web Holdings (NYSEARCA:CWEB) announced that the audit of its 2019 hemp harvest is complete.

After Green Growth Brands reported its earnings, Eight Capital downgraded the stock from “buy” to “sell.” Currently, three analysts follow the company.

On Monday, Curaleaf (OTCMKTS:CURLF) announced that it will acquire BlueKudu—a company that produces premium cannabis chocolates and gummies.

On Tuesday, GW Pharmaceuticals reported its fourth-quarter earnings. The company reported revenue of $109.1 million, which beat analysts’ expectations.

IIPR will report its results for the fourth quarter of 2019 today after the market closes. Analysts expect the company to post revenue and EPS growth.

On Tuesday, GW Pharmaceuticals reported its fourth-quarter earnings after the market closed. For the quarter, the company reported revenue of $109.1 million.

On Monday, Green Growth Brands reported its earnings results for the second quarter of fiscal 2020. The company reported revenues of $21.1 million.

Green Growth Brands will likely report its results for the second quarter of fiscal 2020 on February 24. Analysts expect the company’s revenue to rise sequentially.

President Trump introduced a proposal to end an existing policy introduced by Congress. The proposal will be part of the fiscal 2021 budget plan.

After Curaleaf completed the acquisition of the Select brand, Russell Stanley of Beacon Securities reiterated his “buy” rating.

Yesterday, IIPR announced that it bought a licensed cannabis processing facility in Toledo, Ohio, from Green Thumb Industries for $2.9 million.

On Thursday, Cresco Labs announced that it signed an agreement for a senior secured term loan for an initial aggregate principal amount of $100 million.

Analysts expect Cresco Labs to report revenues of $45.3 million in the fourth quarter to take the total revenue for 2019 to $131.9 million.

On Monday, Russell Stanley of Beacon Securities reiterated his “buy” rating for Curaleaf Holdings. He gave a target price of 25 Canadian dollars.

Although 2019 was tough for Charlotte’s Web Holdings, it has made a significant recovery this year. The stock has increased by 14.8% YTD as of Monday.

Acquisitions could boost Curaleaf’s production and retail footprint significantly. With the EBITDA expected to rise over the next two years, there’s significant upside.

There was hope that cannabis legalization would see daylight in Florida in 2020. However, the state faces some hurdles.

KushCo Holdings reported its Q1 earnings on January 8. KushCo reported revenue of $34.96 million, below analysts’ forecast of $41.5 million.

According to a report by Barron’s on January 7, Stifel analysts expect a rebound in the cannabis sector in the first half of 2020.

Yesterday, OrganiGram stock was trading at 2.68 Canadian dollars, 23.4% lower than when the company reported its fourth-quarter earnings on November 25.

The downward momentum in cannabis stocks has continued today, marking the third straight day of decline for the cannabis sector.

Florida’s “Make It Legal Florida” measure could push other states to look at cannabis legalization. However, President Trump doesn’t seem supportive.

On the back of the weakness in the broader equity market, the cannabis sector traded in the red today. At 1:28 PM ET, the S&P 500 Index was down by 0.4%.

On June 25, Illinois governor J.B. Pritzker signed a bill approving marijuana use for everyone over 21 years old. The law became effective on January 1.

Curaleaf (CURLF) seems to be in a good position in 2019 compared to other cannabis players. Can it keep up its performance in 2020?

On December 26, a Santa Claus rally seems to be in full swing. This effect pushed the S&P 500 (SPX) and Nasdaq Composite Index (COMP) to record highs.

It seems that despite the tough market conditions, institutional investors are still keen to invest in the cannabis sector.

Beacon Securities analyst Russell Stanley expects Curaleaf stock to grow 255% in the next 12 months. Stanley gave a target price of 25 Canadian dollars.

Boosted by the strong performance from the broader equity market, the cannabis sector was trading in the green today.

Curaleaf Holdings (CURLF) (CURA) is one of the leading vertically integrated cannabis players in the US. The company has operations in 12 states.

Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.

Curaleaf stock is up year-to-date by 16.67%, but is down 9.19% from $6.09 on November 29 to $5.53 on December 16. Is it a good buy in December?

The optimistic guidance and initiatives helped MedMen stock rise. On Thursday, the stock closed the day at 0.71 Canadian dollars.

Following Supreme Cannabis’s weak first-quarter performance, PI Financial and Canaccord Genuity lowered their target prices.

Since Florida legalized medical marijuana, business is booming. In September, the state had 22 licensed vertically integrated medical cannabis operators.

The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.

There have been no rating changes since MedMen reported its Q1 earnings. Six of eight analysts gave the stock a “hold” rating.

Despite the weakness in the broader US equity market today, the cannabis sector is trading in the green. Let’s see who’s making big moves today.

Charlotte’s Web Holdings (CWEB) (CWBHF) is one of the latest cannabis companies to be served with a class-action lawsuit.

Cannabis retailer MedMen (MMNFF)(MMEN) reported its first quarter of fiscal 2020 earnings results yesterday. Here’s what you need to know.

Cresco Labs reported its third-quarter earnings on Tuesday after the market closed. The company missed analysts’ top-line and bottom-line estimates.

For the first quarter of 2020 ending in September, Green Growth Brands reported revenues of $12.7 million—an increase of 77% sequentially.